Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Clinical trial NCT04294511 · UNKNOWN
Trial details
- NCT number
- NCT04294511
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-26
- Primary completion
- 2021-03-16
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.